Logo image of LIVN

LIVANOVA PLC (LIVN) Stock Price, Quote, News and Overview

NASDAQ:LIVN - Nasdaq - GB00BYMT0J19 - Common Stock - Currency: USD

41.88  -1.3 (-3.01%)

After market: 41.88 0 (0%)

LIVN Quote, Performance and Key Statistics

LIVANOVA PLC

NASDAQ:LIVN (5/23/2025, 8:31:57 PM)

After market: 41.88 0 (0%)

41.88

-1.3 (-3.01%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High61.94
52 Week Low32.48
Market Cap2.28B
Shares54.35M
Float54.14M
Yearly DividendN/A
Dividend YieldN/A
PE11.9
Fwd PE10.43
Earnings (Next)07-29 2025-07-29/bmo
IPO10-19 2015-10-19


LIVN short term performance overview.The bars show the price performance of LIVN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10

LIVN long term performance overview.The bars show the price performance of LIVN in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30

The current stock price of LIVN is 41.88 USD. In the past month the price increased by 12.4%. In the past year, price decreased by -29.73%.

LIVANOVA PLC / LIVN Daily stock chart

LIVN Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 27.47 227.72B
ISRG INTUITIVE SURGICAL INC 70.62 193.38B
BSX BOSTON SCIENTIFIC CORP 38.7 154.56B
SYK STRYKER CORP 30.06 143.75B
MDT MEDTRONIC PLC 14.67 103.48B
BDX BECTON DICKINSON AND CO 12.16 49.21B
EW EDWARDS LIFESCIENCES CORP 28.84 44.09B
IDXX IDEXX LABORATORIES INC 44 40.65B
RMD RESMED INC 26.74 35.61B
DXCM DEXCOM INC 51.22 33.14B
GEHC GE HEALTHCARE TECHNOLOGY 15.03 31.66B
STE STERIS PLC 26.02 23.87B

About LIVN

Company Profile

LIVN logo image LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. The firm designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, Neuromodulation and Advanced Circulatory Support (ACS). Cardiopulmonary segment is engaged in the design, development, manufacture, marketing and selling of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula and other related accessories. The company includes the Essenz Perfusion System, the Company’s next-generation HLM with an embedded patient monitor for tailored patient care strategies. Neuromodulation segment is engaged in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). The ACS segment is engaged in the development, production, and sale of temporary life support products.

Company Info

LIVANOVA PLC

20 Eastbourne Terrace

London W2 6LG GB

CEO: Damien McDonald

Employees: 2900

LIVN Company Website

LIVN Investor Relations

Phone: 442033250662

LIVANOVA PLC / LIVN FAQ

What is the stock price of LIVANOVA PLC today?

The current stock price of LIVN is 41.88 USD. The price decreased by -3.01% in the last trading session.


What is the ticker symbol for LIVANOVA PLC stock?

The exchange symbol of LIVANOVA PLC is LIVN and it is listed on the Nasdaq exchange.


On which exchange is LIVN stock listed?

LIVN stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for LIVANOVA PLC stock?

16 analysts have analysed LIVN and the average price target is 61.88 USD. This implies a price increase of 47.76% is expected in the next year compared to the current price of 41.88. Check the LIVANOVA PLC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is LIVANOVA PLC worth?

LIVANOVA PLC (LIVN) has a market capitalization of 2.28B USD. This makes LIVN a Mid Cap stock.


How many employees does LIVANOVA PLC have?

LIVANOVA PLC (LIVN) currently has 2900 employees.


What are the support and resistance levels for LIVANOVA PLC (LIVN) stock?

LIVANOVA PLC (LIVN) has a support level at 41.87 and a resistance level at 43.86. Check the full technical report for a detailed analysis of LIVN support and resistance levels.


Is LIVANOVA PLC (LIVN) expected to grow?

The Revenue of LIVANOVA PLC (LIVN) is expected to grow by 6.37% in the next year. Check the estimates tab for more information on the LIVN EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy LIVANOVA PLC (LIVN) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does LIVANOVA PLC (LIVN) stock pay dividends?

LIVN does not pay a dividend.


When does LIVANOVA PLC (LIVN) report earnings?

LIVANOVA PLC (LIVN) will report earnings on 2025-07-29, before the market open.


What is the Price/Earnings (PE) ratio of LIVANOVA PLC (LIVN)?

The PE ratio for LIVANOVA PLC (LIVN) is 11.9. This is based on the reported non-GAAP earnings per share of 3.52 and the current share price of 41.88 USD. Check the full fundamental report for a full analysis of the valuation metrics for LIVN.


What is the Short Interest ratio of LIVANOVA PLC (LIVN) stock?

The outstanding short interest for LIVANOVA PLC (LIVN) is 3.32% of its float. Check the ownership tab for more information on the LIVN short interest.


LIVN Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to LIVN. When comparing the yearly performance of all stocks, LIVN is a bad performer in the overall market: 80.66% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

LIVN Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to LIVN. There are concerns on the financial health of LIVN while its profitability can be described as average.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

LIVN Financial Highlights

Over the last trailing twelve months LIVN reported a non-GAAP Earnings per Share(EPS) of 3.52. The EPS increased by 13.18% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -8.68%
ROE -21.48%
Debt/Equity 0.53
Chartmill High Growth Momentum
EPS Q2Q%20.55%
Sales Q2Q%7.46%
EPS 1Y (TTM)13.18%
Revenue 1Y (TTM)7.62%

LIVN Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 81% to LIVN. The Buy consensus is the average rating of analysts ratings from 16 analysts.

For the next year, analysts expect an EPS growth of 10.36% and a revenue growth 6.37% for LIVN


Ownership
Inst Owners104.09%
Ins Owners0.23%
Short Float %3.32%
Short Ratio2.06
Analysts
Analysts81.25
Price Target61.88 (47.76%)
EPS Next Y10.36%
Revenue Next Year6.37%